Alterity Therapeutics
ATHE | NASDAQ
$1.96
$0.00 (0.00%)
At close: Nov 16, 2026, 4:00 PM ET
$1.96
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:10 PM ET
+0.00%
(1D)No price chart data available for 1D timeframe.
Rating
32.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #728/1021 (Top 71%)
Key Statistics
Market Data
Market Cap $35.53M
1D Range
1.89 1.96
52W Range
1.89 5.89
Valuation (TTM)
PE -2.19
PB 1.20
EV/EBITDA -0.50
Valuation (NTM)
Forward PE N/A
Forward PEG 0.06
Price Target $10.00
Cash Flow
FCF Yield 0.0%
SBC Adj. FCF Yield 0.0%
SBC Impact N/A
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -84.1% |
-9.1%
Dil EPS 3Y | 5Y 38.4% |
43.4%
FCF 3Y | 5Y 61.5% |
12.0%
Returns
ROA -50.9%
ROE -48.3%
ROIC -57.6%
Financial Health
Net Cash
A$37.26M ($25.78M)
Current Ratio 14.52
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Alterity Therapeutics Limited, an Australian biopharmaceutical firm, focuses on the discovery and development of novel drug treatments for various neurological disorders, such as Alzheimer's, Huntingt...
Sector Healthcare
Industry Biotechnology
Employees 11
IPO Date Sep 29, 2003
Website alteritytx.com
Fiscal Year July - June
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove ATHE